The Microbiology Division of DMCUL consists of Microbiology, Virology, Serology and Molecular Infectious Disease Laboratories. The Microbiology Division has 78 full time employees including two M.D. medical directors, two Ph.D technical directors, two supervisors, 52 ASCP certified medical technologists and 20 laboratory assistants. With an average of 15 years of experience in clinical microbiology per medical technologist, our highly trained staff provides a high level of expertise and service.
The Core Microbiology Laboratory incorporates bacteriology (aerobic and anaerobic), mycobacteriology, mycology, parasitology, and antimicrobial susceptibility testing while operating continuously 24 hours a day, seven days a week. Our Laboratory is considered a high volume and highly complex environment that performed more than 1.2 million billable tests in 2008 including nearly 100,000 blood cultures. In order to efficiently process such a large number of blood cultures while maintaining an excellent turnaround time for the clinician, the laboratory was one of the first in the nation to utilize advanced PNA-FISH technology with all qualifying blood cultures. This advancement allows for the identification of serious pathogens such as Staphylococcus aureus, Candida albicans and Enterococcus faecalis within 3- 8 hours of positive growth (compared to 12-48 hours using conventional methods).
Our commitment to continual improvement in service and patient care has resulted in the implementation of numerous technological enhancements to allow for higher throughput and faster turnaround times. One example of such an enhancement is the recent implementation of the BD Affirm™ VPIII Microbial Identification Test; utilized to provide a more accurate and expedient identification of vaginitis through the use of molecular probes for Candida species, Gardnerella vaginalis and Trichomonas vaginalis. This single test can replace the independently ordered 12,000 bacterial vaginosis smears, 14,000 Trichomonas cultures and 14,000 yeast cultures received annually, allowing for more accurate and rapid identification for clinicians.